Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Artemis Medicare
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Artemis Medicare

WEBSITE BSE:542919 NSE: ARTEMISMED Inc. Year: 2004 Industry: Hospital & Healthcare Services My Bucket: Add Stock

₹234.1 1.4 | 0.6%

Last updated: 15:57

Consolidated Standalone

Last updated: 15:57

Artemis Medicare Overview

Artemis Medicare Services Ltd manages and operates multi-speciality hospitals in India and across the world. The company offers scientific and surgical intervention; and inpatient and outpatient offerings. It additionally operates Artemis Hospital, a 395 bed multi-speciality health facility placed in Gurugram, India. The business enterprise changed into incorporated in 2004 and is based in Gurugram, India.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Artemis Medicare Key Financials

Market Cap ₹3706 Cr.

Stock P/E 45.1

P/B 3.2

Current Price ₹234.1

Book Value ₹ 73.7

Face Value 1

52W High ₹297.7

Dividend Yield 0.19%

52W Low ₹ 202.9

Edit Ratio

Artemis Medicare Share Price

₹ | |

Volume
Price

Artemis Medicare Quarterly Price

Quarterly Monthly
Show Value Show %

Artemis Medicare Peer Comparison

Artemis Medicare Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 225 219 225 223 241 232 240 255 275 272
Other Income 2 2 2 4 7 9 12 7 8 7
Total Income 227 221 227 228 249 241 252 262 282 280
Total Expenditure 191 186 187 187 199 195 204 214 224 228
Operating Profit 37 34 40 41 50 46 48 48 58 52
Interest 8 8 9 8 8 8 8 7 7 7
Depreciation 10 10 11 11 11 11 12 11 12 12
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -3
Profit Before Tax 19 16 20 22 31 27 29 30 39 30
Provision for Tax 5 5 6 5 8 6 6 9 9 8
Profit After Tax 14 12 14 17 22 21 23 21 30 22
Adjustments 0 -0 -0 0 0 0 0 0 -0 0
Profit After Adjustments 14 12 14 17 22 21 23 21 30 22
Adjusted Earnings Per Share 1 0.9 1 1.2 1.6 1.5 1.7 1.5 2.2 1.4

Artemis Medicare Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 547 565 408 555 737 879 937 1042
Other Income 4 5 4 5 7 7 33 34
Total Income 551 570 412 560 745 886 970 1076
Total Expenditure 483 504 373 488 643 746 785 870
Operating Profit 68 66 39 71 101 140 185 206
Interest 11 13 13 12 20 31 32 29
Depreciation 20 23 22 22 31 40 45 47
Exceptional Income / Expenses 0 0 3 0 0 0 0 -3
Profit Before Tax 37 31 8 37 51 68 108 128
Provision for Tax 16 11 1 6 13 19 25 32
Profit After Tax 20 19 6 31 38 49 82 96
Adjustments 0 0 0 0 1 -0 0 0
Profit After Adjustments 20 20 6 32 39 49 83 96
Adjusted Earnings Per Share 0 1.5 0.5 2.4 2.9 3.6 6 6.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 7% 19% 11% 0%
Operating Profit CAGR 32% 38% 23% 0%
PAT CAGR 67% 38% 34% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -15% 46% 65% NA%
ROE Average 14% 14% 11% 10%
ROCE Average 17% 16% 13% 13%

Artemis Medicare Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 293 313 320 359 403 448 838
Minority's Interest -0 0 2 2 5 6 6
Borrowings 53 66 108 161 214 228 209
Other Non-Current Liabilities 31 49 61 65 103 135 130
Total Current Liabilities 177 158 118 138 206 185 216
Total Liabilities 554 586 609 726 930 1002 1399
Fixed Assets 381 393 383 489 605 719 745
Other Non-Current Assets 61 76 116 110 155 103 116
Total Current Assets 113 118 109 127 170 180 539
Total Assets 554 586 609 726 930 1002 1399

Artemis Medicare Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 4 9 12 19 16 23 15
Cash Flow from Operating Activities 40 56 27 60 127 109 146
Cash Flow from Investing Activities -50 -26 -37 -107 -158 -88 -385
Cash Flow from Financing Activities 14 -27 18 44 38 -29 267
Net Cash Inflow / Outflow 5 2 8 -3 7 -8 27
Closing Cash & Cash Equivalent 9 12 19 16 23 15 42

Artemis Medicare Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0 1.5 0.49 2.4 2.88 3.62 6
CEPS(Rs) 0 3.18 2.09 4.05 5.15 6.58 9.25
DPS(Rs) 0 0 0 0 0.45 0.45 0.45
Book NAV/Share(Rs) 0 18.68 19.17 21.51 24.43 27.52 55.63
Core EBITDA Margin(%) 11.68 10.88 8.62 11.98 12.74 15.1 16.2
EBIT Margin(%) 8.74 7.69 5.01 8.86 9.53 11.35 14.9
Pre Tax Margin(%) 6.72 5.42 1.84 6.7 6.86 7.79 11.49
PAT Margin (%) 3.73 3.44 1.51 5.66 5.15 5.59 8.77
Cash Profit Margin (%) 7.4 7.45 6.78 9.66 9.36 10.18 13.59
ROA(%) 3.68 3.41 1.03 4.71 4.59 5.09 6.84
ROE(%) 9.5 8.43 2.46 11.66 12.41 14.01 14.43
ROCE(%) 13.96 12.64 5.63 11.47 13.34 16.47 16.93
Receivable days 52.5 50.13 58.68 42.15 41.25 39.07 38.21
Inventory Days 4.63 5.71 9.11 7.24 6.53 5 3.91
Payable days 205.99 194.88 206.67 138.01 141.52 152.49 156.98
PER(x) 0 9.23 45.31 19.1 23.65 46.95 45.76
Price/Book(x) 0 0.74 1.16 2.13 2.79 6.17 4.94
Dividend Yield(%) 0 0 0 0 0.66 0.27 0.16
EV/Net Sales(x) 0.19 0.47 0.96 1.38 1.5 2.84 3.88
EV/Core EBITDA(x) 1.5 4.01 10.07 10.7 10.89 17.84 19.65
Net Sales Growth(%) 0 3.39 -27.72 35.85 32.92 19.14 6.64
EBIT Growth(%) 0 -9.04 -52.9 140.33 42.97 41.91 39.98
PAT Growth(%) 0 -4.55 -68.35 409.76 21.05 29.29 67.21
EPS Growth(%) 0 0 -67.23 390.47 19.75 25.68 66.01
Debt/Equity(x) 0.53 0.4 0.5 0.64 0.74 0.68 0.32
Current Ratio(x) 0.64 0.74 0.92 0.92 0.83 0.98 2.49
Quick Ratio(x) 0.6 0.68 0.84 0.83 0.76 0.92 2.45
Interest Cover(x) 4.34 3.39 1.58 4.11 3.57 3.19 4.37
Total Debt/Mcap(x) 0 0.54 0.43 0.3 0.26 0.11 0.07

Artemis Medicare Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 68.03 68.03 67.51 67.17 67.17 67.17 66.53 66.53 58.39 58.39
FII 0.11 0.1 0.16 0.22 0.64 0.31 0.24 0.37 12.47 12.19
DII 9.13 9.78 10.57 10.69 11.59 12.13 11.78 11.29 9.07 9.05
Public 22.72 22.08 21.76 21.92 20.6 20.39 21.46 21.81 20.08 20.37
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Artemis Medicare News

Artemis Medicare Pros & Cons

Pros

  • Company has delivered good profit growth of 33% CAGR over last 5 years
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 14% over the last 3 years.
  • Debtor days have increased from 152.49 to 156.98days.
  • Stock is trading at 3.2 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!